Kovi Bessoff

Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests

Elizabeth A. Hunsperger, Sutee Yoksan, Philippe Buchy et al. · Emerging infectious diseases · 2009 · 239 citations · Full text

Comparison of Two Commercially Available Dengue Virus (DENV) NS1 Capture Enzyme-Linked Immunosorbent Assays Using a Single Clinical Sample for Diagnosis of Acute DENV Infection

Kovi Bessoff, Mark J. Delorey, Wellington Sun et al. · Clinical and Vaccine Immunology · 2008 · 155 citations · Full text

Diagnostic Virology, Dengue Virus, Viral Diagnostics +11

Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium parvum Growth

Kovi Bessoff, Adam Sateriale, K. Kyungae Lee et al. · Antimicrobial Agents and Chemotherapy · 2013 · 135 citations · Full text

Microbial Pathogens, Diarrheal Disease, Antiparasitic Agent +21

Identification of Cryptosporidium parvum Active Chemical Series by Repurposing the Open Access Malaria Box

Kovi Bessoff, Thomas Spangenberg, Jenna E. Foderaro et al. · Antimicrobial Agents and Chemotherapy · 2014 · 77 citations · Full text

A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box

Rajiv S. Jumani, Kovi Bessoff, Melissa S. Love et al. · Antimicrobial Agents and Chemotherapy · 2018 · 65 citations · Full text